S

Sharon Bio-Medicine Ltd

SHARONBIO

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sharon Bio-Medicine Ltd insights

29 extracted metrics + investor summaries across FY16–FY23.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Growth Rate

Revenue Growth
4.00% →
Net Income Growth
8.00% →
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Quarterly Results

  Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023
Sales
45.79
35.8
43.25
45.24
48.57
48.89
45.37
44.36
49.77
37.84
55.16
57.75
44.23
Expenses
37.71
31.81
38.6
38.72
42.11
42.27
38.52
38.01
43.4
36.99
44.46
47.46
40.72
Operating Profit
8.08
3.99
4.65
6.52
6.46
6.62
6.85
6.35
6.37
0.85
10.7
10.29
3.51
OPM %
17.65%
11.15%
10.75%
14.41%
13.3%
13.54%
15.1%
14.31%
12.8%
2.25%
19.4%
17.82%
7.94%
Other Income
0.49
0.38
0.64
1.01
2.08
0.66
0.47
0.56
1.13
0.72
0.85
2.09
0.79
Interest
0.04
0.04
0.04
0.05
0.04
0.03
0.03
0.03
0.02
0.02
0.02
0.01
0.01
Depreciation
2.5
2.83
2.88
2.91
2.89
2.76
2.82
2.85
2.8
2.66
2.69
2.91
2.49
PBT
6.03
1.5
2.37
4.57
5.61
4.49
4.47
4.03
4.68
-1.11
8.84
9.46
1.8
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
6.03
1.5
2.37
4.56
5.61
4.49
4.48
4.02
4.68
-1.11
8.85
9.47
1.81
EPS in Rs
0.51
0.13
0.2
0.38
0.47
0.38
0.38
0.34
0.39
-0.09
0.74
0.8
0.15
Figures in ₹ Crores

Profit & Loss

  Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016 9mMar 2020Mar 2021Mar 2022Mar 2023
Sales
420
496
606
785
1,060
1,314
834
253
171
173
188
195
Expenses
381
445
535
690
939
1,157
868
387
145
151
162
170
Operating Profit
39
52
71
95
120
157
-34
-134
26
22
26
25
OPM %
9%
10%
12%
12%
11%
12%
-4.1%
-53%
15%
13%
14%
13%
Other Income
2
0
1
1
1
2
-74
-69
-72
4
3
4
Interest
14
21
27
34
43
59
94
71
0
0
0
0
Depreciation
4
6
8
9
12
15
19
15
11
12
11
11
PBT
22
24
36
53
66
85
-221
-289
-56
14
18
19
Tax %
16%
22%
15%
22%
20%
18%
2%
3%
0%
0%
0%
0%
Net Profit
19
19
31
42
53
70
-226
-299
-56
14
18
19
EPS in Rs
1.76
1.77
2.95
3.94
5.01
6.59
-18.99
-25.16
-4.75
1.18
1.49
1.6
Div. Payout %
7%
8%
6%
5%
3%
5%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

  Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016Mar 2020Mar 2021Mar 2022Mar 2023
Equity Capital
11
11
11
11
11
21
24
24
24
1
1
1
Reserves
96
112
188
182
233
323
94
-205
-664
-627
-610
-592
Borrowings
262
343
344
508
644
725
824
836
828
828
828
828
Other Liabilities
29
35
44
74
84
92
69
68
88
88
80
76
Total Liabilities
397
501
586
774
972
1,162
1,012
723
276
290
299
313
Fixed Assets
56
184
181
201
272
325
332
319
149
141
135
128
CWIP
107
23
27
60
43
15
0
0
0
0
0
0
Investments
1
4
4
4
4
1
1
0
0
0
0
0
Other Assets
233
290
374
509
654
820
678
404
128
149
164
185
Total Assets
397
501
586
774
972
1,162
1,012
723
276
290
299
313
Figures in ₹ Crores

Cash Flow

  Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016Mar 2020Mar 2021Mar 2022Mar 2023
Operating
-50
-28
-36
-53
-70
-69
-82
-28
35
4
23
41
Investing
-66
-51
-8
-61
-64
-27
-10
0
-7
-4
-3
-3
Financing
47
78
46
117
134
103
96
22
0
0
0
0
Net Cash Flow
-69
-1
1
2
0
6
4
-6
28
0
20
38
Free Cash Flow
-121
-78
-46
-115
-135
-101
-93
-30
27
0
18
36
CFO/OP
-129
-55
-51
-56
-58
-44
238
21
133
19
86
160
Figures in ₹ Crores

Ratios

  Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days
116
117
116
121
122
115
138
264
47
62
52
49
Inventory Days
90
102
112
109
105
106
136
198
173
209
162
149
Days Payable
23
23
23
28
24
20
23
44
214
183
167
155
Cash Conversion Cycle
183
195
205
202
203
201
251
418
7
88
48
43
Working Capital Days
176
188
72
78
72
79
129
68
-566
-514
-464
-474
ROCE %
11%
11%
13%
14%
14%
15%
-5%
-17%
—
7%
8%
8%

Shareholding Pattern

As of Mar 2023
Public 99.98%
DIIs 0.02%
Total 100.00%
  Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023
Promoters
32.53%
32.53%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
DIIs
0.01%
0.01%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
Public
67.46%
67.46%
99.97%
99.97%
99.98%
99.97%
99.97%
99.97%
99.97%
99.99%
99.99%
99.98%
No. of Shareholders
24,836
24,830
24,854
24,854
24,854
24,854
24,854
24,854
24,853
24,837
24,837
24,837

Documents

Frequently Asked Questions about Sharon Bio-Medicine Ltd

What does Sharon Bio-Medicine Ltd do?
Sharon Bio-Medicine Limited is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of pharmaceutical products. The Company operates in three segments, which include Active Pharma Ingredients (API's), Formulations and Toxicology.
Where is Sharon Bio-Medicine Ltd (SHARONBIO) listed?
Sharon Bio-Medicine Ltd is listed on the Indian stock exchanges. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Sharon Bio-Medicine Ltd belong to?
Sharon Bio-Medicine Ltd operates in the Healthcare sector within the Pharmaceuticals & Biotechnology industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
How can I research Sharon Bio-Medicine Ltd on Tapetide?
On Tapetide, you can view Sharon Bio-Medicine Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Sharon Bio-Medicine Limited is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of pharmaceutical products. The Company operates in three segments, which include Active Pharma Ingredients (API's), Formulations and Toxicology.

Website sharonbio.com
Face Value ₹ 2

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List